Opinion: Don’t villainize the biopharma industry. It offers hope to people like me
The biopharma industry is often painted as a villain. But from my perspective as someone with a rare disease, that label is scarily without nuance.
I enjoy watching “60 Minutes” on Sundays. Two recent episodes focused on drugs companies. Both of the stories were negative, and deservedly so. But they made me wonder.
One was about Purdue Pharma, a company that has misled doctors and patients about how addictive its drug OxyContin actually is. The other was about Kaleo, a company that has jacked up the price of naloxone, a drug that counteracts opioid overdoses.
Those stories made
